A retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: Analysis of albumin-bilirubin (ALBI) grade.

Authors

null

Iori Motoo

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Iori Motoo , Yoshito Komatsu , Satoshi Yuki , Shintaro Nakano , Hiroshi Nakatsumi , Yasuyuki Kawamoto , Tetsuhito Muranaka , Kentaro Sawada , Takayuki Ando , Takuto Miyagishima , Kazuaki Harada , Yoshimitsu Kobayashi , Kazuteru Hatanaka , Atsushi Ishiguro , Aya Tanimoto , Takuya Honda , Masayoshi Dazai , Takahide Sasaki , Naoya Sakamoto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 415)

Abstract #

415

Poster Bd #

G4

Abstract Disclosures

Similar Posters

Poster

2017 Gastrointestinal Cancers Symposium

Association of <i>UGT1A1</i> gene polymorphism with the safety and efficacy of irinotecan monotherapy for advanced gastric cancer.

Association of UGT1A1 gene polymorphism with the safety and efficacy of irinotecan monotherapy for advanced gastric cancer.

First Author: Toshifumi Yamaguchi

First Author: Daisuke Takahari